Related Experiment Video

Updated: Jun 28, 2026

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research
10:10

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Published on: November 2, 2018

9.1K

Response: Promise and open questions of optogenetic vision restoration by MCO

Samarendra K Mohanty1, Santosh Mahapatra2, Subrata Batabyal1

  • 1Nanoscope Therapeutics, Inc., 2777 N. Stemmons Freeway, Dallas, TX 75207, USA.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|April 25, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro
12:56

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro

Published on: December 19, 2017

7.7K
Using Looming Visual Stimuli to Evaluate Mouse Vision
05:07

Using Looming Visual Stimuli to Evaluate Mouse Vision

Published on: June 13, 2019

11.1K

Related Experiment Videos

Last Updated: Jun 28, 2026

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research
10:10

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Published on: November 2, 2018

9.1K
Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro
12:56

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro

Published on: December 19, 2017

7.7K
Using Looming Visual Stimuli to Evaluate Mouse Vision
05:07

Using Looming Visual Stimuli to Evaluate Mouse Vision

Published on: June 13, 2019

11.1K

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...

Articles linked to this work by shared authors, journal, and citation graph.

Persistent Cytotoxic Immune Signaling in Anti-VEGF-Treated Neovascular Age-Related Macular Degeneration.

medRxiv : the preprint server for health sciences·2026

Insights into longevity and virus-driven adaptation from Myotis bat genomes.

Nature·2026

Stimulant Use Disorder.

Primary care·2026

Vitreoretinal procedures in inherited retinal diseases: a large retrospective cohort study.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2026

Management of large submacular hemorrhage in a patient undergoing neurosurgical intervention for moyamoya.

Digital journal of ophthalmology : DJO·2026

Paired longitudinal tear proteomics reveals persistent ocular surface dysregulation after teprotumumab therapy in thyroid eye disease.

Communications medicine·2026

Multiplexed genome editing by CRISPR-Un1Cas12f1 restores dystrophin expression in a mouse model of Duchenne muscular dystrophy.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

A phase 1/2 dose-escalation study of sepiapterin in patients with 6-pyruvoyl-tetrahydropterin synthase deficiency with hyperphenylalaninemia.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

D-Amino Acid Prodrug DLMEH Activates mTORC1 via Sestrin2 to Restore Muscle Protein Synthesis in Sarcopenia.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Combination Of Bispecific Antibodies Enable Targeted TNFRSF Agonism and Effective Antitumor Activity.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Protein-based masks to unlock conditional activation of therapeutics.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Optimization of AsCas12f1-Mediated Long-Term Gene Repression.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

No-Show Propensity and Loss to Follow-Up Among Glaucoma Patients: A Retrospective Cohort Study.

Ophthalmic epidemiology·2026

Anterior Chamber Angle Alterations in Bilateral Acute Iris Transillumination Syndrome.

Ocular immunology and inflammation·2026

High Adhesion Superoleophobic Oil Microdroplets to Create Ocular Hypertension In Vivo.

Small (Weinheim an der Bergstrasse, Germany)·2026

Effect of Intracameral Air Injection on Corneal Endothelial Cell Loss After Phacoemulsification for Cataracts of LOCS III Nuclear Grade 4 or Higher: A Randomised Clinical Trial.

Clinical & experimental ophthalmology·2026

Orbital Asymmetry in Congenital Ptosis.

The Journal of craniofacial surgery·2026

From optical control to translational readiness: an evidence-tiered framework for optogenetics in neuromuscular and neurological disorders.

Materials today. Bio·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us